We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Doximity (DOCS - Free Report) will report quarterly earnings of $0.34 per share in its upcoming release, pointing to a year-over-year decline of 24.4%. It is anticipated that revenues will amount to $170.66 million, exhibiting an increase of 1.3% compared to the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Doximity metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Revenues- Other' of $9.68 million. The estimate suggests a change of +6.9% year over year.
Based on the collective assessment of analysts, 'Revenues- Subscription' should arrive at $161.16 million. The estimate points to a change of +1.1% from the year-ago quarter.
The combined assessment of analysts suggests that 'Number of customers with at least $500,000 of TTM revenue' will likely reach 129 . Compared to the present estimate, the company reported 121 in the same quarter last year.
Over the past month, shares of Doximity have returned +15% versus the Zacks S&P 500 composite's -2.3% change. Currently, DOCS carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Doximity (DOCS - Free Report) will report quarterly earnings of $0.34 per share in its upcoming release, pointing to a year-over-year decline of 24.4%. It is anticipated that revenues will amount to $170.66 million, exhibiting an increase of 1.3% compared to the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Doximity metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Revenues- Other' of $9.68 million. The estimate suggests a change of +6.9% year over year.
Based on the collective assessment of analysts, 'Revenues- Subscription' should arrive at $161.16 million. The estimate points to a change of +1.1% from the year-ago quarter.
The combined assessment of analysts suggests that 'Number of customers with at least $500,000 of TTM revenue' will likely reach 129 . Compared to the present estimate, the company reported 121 in the same quarter last year.
View all Key Company Metrics for Doximity here>>>Over the past month, shares of Doximity have returned +15% versus the Zacks S&P 500 composite's -2.3% change. Currently, DOCS carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .